Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your Favorites.
This session is in your Favorites. Click again to remove it.
Presentation Icons
ACG Award Winner
ACG Newsworthy Abstract
Registration Required
No CME
On-Demand Video
Livestream
Back
Favorite
Email
Post (Tweet)
Rupayan Kundu, MD (he/him/his)
Cleveland Clinic Foundation
Poster(s):
P0913 - How Many Doses of Infliximab Should Be Used in Immune Checkpoint Inhibitor-Induced Colitis? – A Retrospective Study
Sunday, October 27, 2024
3:30 PM – 7:00 PM
ET
Email Rupayan